JSKN022 in Subjects With Advanced Malignant Solid Tumors

Clinical trial NCT07292402 · RECRUITING

Trial details

NCT number: NCT07292402
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2025-10-23
Primary completion: 2027-08-31
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.